Pure Global
NCT05480059

Assessment of Psychological Symptoms and Health Related Quality of Life in Patients With Irritable Bowel Syndrome

Assiut University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
IBS - Irritable Bowel Syndrome
Drug/Device/Intervention
A questionnaire
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2022
End date
Nov 01, 2023
Enrollment
80 participants
Primary outcome

Psychiatric Co-morbidities and Health-related Quality of life in Patients with Irritable Bowel Syndrome

Summary

To evaluate the relation between the clinical presentations and the psychiatric
 co-morbidities with the quality of life in patients with irritable bowel syndrome.

ICD-10 classifications
Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05480059
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05480059 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.